Clinical Trial Update: Fixed Combination for Lipid and Blood Pressure Control [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a fixed-dose combination for lipid and blood pressure control was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension
• Dyslipidemias

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Arterial Hypertension, Dyslipidemias | Phase 4 | Status: WITHDRAWN